Post-transplant lymphoproliferative disorder: A single-center experience

Transplantation Proceedings

Volumn 47, Issue 4, 2015, Pages 981-984

  Ferreira, H ^a   Bustorff, M ^a   Santos, J ^a   Ferreira, I ^a,b   Sampaio, S ^a,b   Salome I ^a   Bastos, J ^a   Bergantim, R ^a,b   Principe F ^a,b   Pestana, M ^a,b,c  

^a Universidade do Porto   (Portugal)

^b University of Porto   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; DACARBAZINE; DOXORUBICIN; EVEROLIMUS; LACTATE DEHYDROGENASE; MYCOPHENOLATE MOFETIL; OKT 3; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VINBLASTINE;

ADULT; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; GENERAL CONDITION DETERIORATION; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSION REDUCTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBDURAL HEMATOMA; ADVERSE EFFECTS; ALLOTRANSPLANTATION; FOLLOW UP; INCIDENCE; LYMPHOPROLIFERATIVE DISORDERS; PORTUGAL; SURVIVAL RATE; TIME; TRENDS;

ADULT; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PORTUGAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84930396233     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.03.017     Document Type: Conference Paper

References (6)

1. K. Mucha, B. Foroncewicz, and B. Ziarkiewicz-Wróblewska Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease? Nephrol Dial Transplant 25 2010 2089 2098
2. A.M. Evens, R. Roy, and D. Sterrenberg Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy Curr Oncol Rep 12 2010 383 394
3. I. Rama, and J.M. Grinyó Malignancy after renal transplantation: the role of immunosuppression Nat Rev Nephrol 6 2010 511 519
4. A.K. Morgans, R. Reshef, and D.E. Tsai Posttransplant lymphoproliferative disorder following kidney transplant Am J Kidney Dis 55 2010 168 180
5. A. Parker, K. Bowles, and J.A. Bradley Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients: BCSH and BTS Guidelines Br J Haematol 149 2010 693 705
6. G. Végso, M. Hajdu, and A. Sebestyén Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options Pathol Oncol Res 17 2011 443 454